<br>Current advances in statin treatment: from molecular mechanisms to clinical practice

Chao-Yung Wang; James K. Liao

ISSN: 1734-1922

Archives of Medical Science Special Issues

Current issue Archive Archives of Medical Science

4/2007

Send email

Copy url:

abstract:

Current advances in statin treatment: from molecular mechanisms to clinical practice

Chao-Yung Wang

,

James K. Liao

Arch Med Sci 2007; 3, 4A: S91-S96

Online publish date: 2008/01/30

View full text Get citation

Statins inhibit cholesterol biosynthesis and are beneficial in the primary and secondary prevention of cardiovascular disease. In some studies, the benefits of statin therapy appear to be greater and to occur much earlier than what might be expected from changes in lipid levels alone. Indeed, statins inhibits the synthesis of isoprenoids, which are important lipid attachments for intracellular signaling molecules such as Rho, Rac, and Cdc42. Inhibition of these signaling molecules may contribute to some of the cholesterol-independent or “pleiotropic” effects of statins. These effects include improvement in endothelial function, stabilization of atherosclerotic plaques, reduction of inflammation and oxidative stress, and inhibition of thrombogenic response. Thus, the overall benefits of statin therapy in cardiovascular disease may be due to cholesterol-dependent and -independent mechanisms.

keywords:

Current advances in statin treatment: from molecular mechanisms to clinical practice

Chao-Yung Wang , James K. Liao

statins, cholesterol, vascular, inflammation, atherosclerosis

Chao-Yung Wang

,

James K. Liao